Advertisement
Australia markets close in 56 minutes
  • ALL ORDS

    7,797.20
    -101.70 (-1.29%)
     
  • ASX 200

    7,546.20
    -95.90 (-1.25%)
     
  • AUD/USD

    0.6399
    -0.0027 (-0.41%)
     
  • OIL

    84.44
    +1.71 (+2.07%)
     
  • GOLD

    2,398.00
    0.00 (0.00%)
     
  • Bitcoin AUD

    97,165.64
    +869.83 (+0.90%)
     
  • CMC Crypto 200

    1,288.86
    +403.32 (+44.41%)
     
  • AUD/EUR

    0.6015
    -0.0015 (-0.26%)
     
  • AUD/NZD

    1.0881
    +0.0006 (+0.06%)
     
  • NZX 50

    11,756.31
    -79.73 (-0.67%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,189.39
    -196.48 (-1.20%)
     
  • NIKKEI 225

    37,016.62
    -1,063.08 (-2.79%)
     

1 Beaten-Down Stock That Has a Lot to Prove in 2023

1 Beaten-Down Stock That Has a Lot to Prove in 2023

The past several years have been brutal for biotech company Bluebird bio (NASDAQ: BLUE). Shares of the gene-editing specialist are down by 85% since early 2020 as it has had to deal with clinical and regulatory setbacks, not to mention the marketwide headwinds that have impacted all equities.